Vir Biotechnology Inc

is a biotechnology company focused on leveraging the immune system to develop transformative therapies for infectious diseases and other serious conditions. It aims to create innovative treatments that harness the power of antibodies and other immune-based technologies to target a variety of diseases, including viral infections and immune-related disorders. Through its cutting-edge research and development efforts, the company seeks to improve health outcomes and provide novel solutions to unmet medical needs, with a particular emphasis on addressing global health challenges.